NDC 71571-333

Eysuvis

Loteprednol Etabonate

Eysuvis is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Kala Pharmaceuticals, Inc.. The primary component is Loteprednol Etabonate.

• Product ID: 71571-333_3e42627b-9893-4de3-821b-9a0ce8aeebf8
• NDC: 71571-333
• Product Type: Human Prescription Drug
• Proprietary Name: Eysuvis
• Generic Name: Loteprednol Etabonate
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2020-11-18
• Marketing Category: NDA / NDA
• Application Number: NDA210933
• Labeler Name: Kala Pharmaceuticals, Inc.
• Substance Name: LOTEPREDNOL ETABONATE
• Active Ingredient Strength: 3 mg/mL
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 71571-333-83

1 BOTTLE, DROPPER in 1 CARTON (71571-333-83) > 8.3 mL in 1 BOTTLE, DROPPER

• Marketing Start Date: 2020-11-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Eysuvis" or generic name "Loteprednol Etabonate"

NDC	Brand Name	Generic Name
71571-333	Eysuvis	loteprednol etabonate
24208-353	Alrex	loteprednol etabonate
71571-121	Inveltys	loteprednol etabonate
24208-299	LOTEMAX	loteprednol etabonate
24208-443	Lotemax	loteprednol etabonate
24208-503	LOTEMAX	loteprednol etabonate
24208-507	Lotemax SM	loteprednol etabonate
17478-830	Loteprednol Etabonate	Loteprednol Etabonate
24208-508	Loteprednol Etabonate	loteprednol etabonate
50383-265	Loteprednol Etabonate	Loteprednol Etabonate
62756-232	Loteprednol Etabonate	Loteprednol Etabonate
68682-299	Loteprednol Etabonate	loteprednol etabonate